Chartsbank is a comprehensive database containing information on more than 3000 new drugs in development, inclusive of pre-clinical research up to phase IV development

Subscribers view details.


 
Please Select Filter Criteria for the drug pipeline
Drug Pipeline by drug name:
Drug Pipeline by Company:
Drug Pipeline by Disease:

Subscribe

Drug Pipeline by Generic :
Drug Pipeline by Current Status:
Drug Pipeline by ICN:

...21222324252627282930...
CompanyDrug NameStatusIndication Group
Cytogen QUADRAMET in Phase IIIAntineoplastic & immunomodulating agents
Vivus Qnexa Phase III initiatedAlimentary tract & metabolism
BioStratum Pyridorin accomplished Phase IIGenito urinary system & sex hormones
Savient Puricase accomplished Phase IIIAlimentary tract & metabolism
SkyePharma Pulmicort HFA Submitted for approval in EURespiratory system
AstraZeneca Pulmicort Approved in USARespiratory system
Unigene Laboratories PTH accomplished Phase IMusculoskeletal system
SkyePharma Psoraxine accomplished Phase IDermatologicals
Viventia Biotech Proxinium in Phase IIAntineoplastic & immunomodulating agents
Cephalon PROVIGIL, ATTENACE, SPARLON discontinuedNervous system
Cephalon PROVIGIL Approved in GermanyNervous system
Dendreon Provenge in Phase IIIAntineoplastic & immunomodulating agents
Dendreon Provenge Submitted for approval in USAAntineoplastic & immunomodulating agents
Provectus Provecta in Phase IIAntineoplastic & immunomodulating agents
Provectus Provecta in Phase IAntineoplastic & immunomodulating agents
Osiris Therapeutics Provacel in Phase ICardiovascular system
Wyeth Protonix in Phase IAlimentary tract & metabolism
Therion Biologics PROSTVAC - VF and Radiation and Chemotherapy in Phase IIAntineoplastic & immunomodulating agents
Therion Biologics PROSTVAC - VF and Immunregulated agents accomplished Phase IIAntineoplastic & immunomodulating agents
Therion Biologics PROSTVAC - VF accomplished Phase IIAntineoplastic & immunomodulating agents
...21222324252627282930...




Drug Pipeline Copyright © 2005- 2017 All Rights Reserved.